BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 22335915)

  • 1. [Comparison of the efficacy of diffusion-weighted imaging and PET-CT in diagnosis of nasopharyngeal cancer].
    Li H; Xie CM; Liu XW
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):791-2. PubMed ID: 22335915
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preliminary study on the validity of whole body diffusion-weighted imaging for the detection of malignant lesions].
    Wang JW; Zhao S; Liu Y; Li J; Xu LM
    Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):304-8. PubMed ID: 20510086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?
    Chen W; Jian W; Li HT; Li C; Zhang YK; Xie B; Zhou DQ; Dai YM; Lin Y; Lu M; Huang XQ; Xu CX; Chen L
    Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-body MRI, including diffusion-weighted imaging, for the initial staging of malignant lymphoma: comparison to computed tomography.
    Kwee TC; van Ufford HM; Beek FJ; Takahara T; Uiterwaal CS; Bierings MB; Ludwig I; Fijnheer R; Nievelstein RA
    Invest Radiol; 2009 Oct; 44(10):683-90. PubMed ID: 19724232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study: diffusion weighted whole body imaging with background body signal suppression and hybrid Positron Emission Computed Tomography on detecting lesions in oncologic clinics.
    Wang N; Zhang M; Sun T; Chen H; Huang Z; Yan L; Wang L; Li F; Chen Z
    Eur J Radiol; 2012 Jul; 81(7):1662-6. PubMed ID: 21477959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses.
    Drzezga A; Souvatzoglou M; Eiber M; Beer AJ; Fürst S; Martinez-Möller A; Nekolla SG; Ziegler S; Ganter C; Rummeny EJ; Schwaiger M
    J Nucl Med; 2012 Jun; 53(6):845-55. PubMed ID: 22534830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential diagnosis of primary nasopharyngeal lymphoma and nasopharyngeal carcinoma focusing on CT, MRI, and PET/CT.
    Cho KS; Kang DW; Kim HJ; Lee JK; Roh HJ
    Otolaryngol Head Neck Surg; 2012 Apr; 146(4):574-8. PubMed ID: 22261493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of diffusion-weighted magnetic resonance imaging compared with fluorodeoxyglucose positron emission tomography/computed tomography for pancreatic malignancy: a meta-analysis using a hierarchical regression model.
    Wu LM; Hu JN; Hua J; Liu MJ; Chen J; Xu JR
    J Gastroenterol Hepatol; 2012 Jun; 27(6):1027-35. PubMed ID: 22414092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body diffusion-weighted imaging: technical improvement and preliminary results.
    Li S; Sun F; Jin ZY; Xue HD; Li ML
    J Magn Reson Imaging; 2007 Oct; 26(4):1139-44. PubMed ID: 17896396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular imaging of malignant tumor metabolism: whole-body image fusion of DWI/CT vs. PET/CT.
    Reiner CS; Fischer MA; Hany T; Stolzmann P; Nanz D; Donati OF; Weishaupt D; von Schulthess GK; Scheffel H
    Acad Radiol; 2011 Aug; 18(8):940-6. PubMed ID: 21718953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using DWIBS MRI technique as an alternative to bone scan or PET scan for whole-body imaging in oncology patients.
    Kachewar SG
    Acta Radiol; 2011 Sep; 52(7):788. PubMed ID: 21852438
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of bone metastases using diffusion weighted magnetic resonance imaging: comparison with (11)C-methionine PET and bone scintigraphy.
    Goudarzi B; Kishimoto R; Komatsu S; Ishikawa H; Yoshikawa K; Kandatsu S; Obata T
    Magn Reson Imaging; 2010 Apr; 28(3):372-9. PubMed ID: 20106624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body diffusion-weighted magnetic resonance imaging: current evidence in oncology and potential role in colorectal cancer staging.
    Lambregts DM; Maas M; Cappendijk VC; Prompers LM; Mottaghy FM; Beets GL; Beets-Tan RG
    Eur J Cancer; 2011 Sep; 47(14):2107-16. PubMed ID: 21664810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing extracranial tumors using diffusion-weighted whole-body MRI.
    Lenz C; Klarhöfer M; Scheffler K; Winter L; Sommer G
    Z Med Phys; 2011 May; 21(2):79-90. PubMed ID: 20888200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma.
    Pfannenberg C; Aschoff P; Schanz S; Eschmann SM; Plathow C; Eigentler TK; Garbe C; Brechtel K; Vonthein R; Bares R; Claussen CD; Schlemmer HP
    Eur J Cancer; 2007 Feb; 43(3):557-64. PubMed ID: 17224266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.
    Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA
    J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of whole body diffusion weighted magnetic resonance imaging and somatostatin receptor scintigraphy for oncogenic osteomalacia.
    Li S; Xue HD; Jiang Y; Xia WB; Jing HL; Chen LB; Sun F; Jin ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct; 34(5):437-42. PubMed ID: 23134817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
    Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
    J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWI.
    Eiber M; Holzapfel K; Ganter C; Epple K; Metz S; Geinitz H; Kübler H; Gaa J; Rummeny EJ; Beer AJ
    J Magn Reson Imaging; 2011 May; 33(5):1160-70. PubMed ID: 21509875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.